Combining Novel Agents for CLL

Jennifer Brown, MD, PhD

Video Categories: CLL

Dr. Jennifer R. Brown talks about combining novel agents for treating CLL as the next step to achieve longer remissions for patients. Until now, novel agents have only been used individually or in combination with antibodies. New studies are being designed to measure the efficacy of combining novel agents with each other for improved outcomes.
September 2, 2015

Challenges with Oral Oncolytics

Dixie-Lee Esseltine, MD and George Mulligan, PhD address the challenges that they foresee for patients as more oral oncolytics are developed.

August 30, 2018

The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung Cancer

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.